Table 2.

Effect of Fas Triggering on CFU-C Growth From CD34+ BM Cells of CML Patients Sensitive or Resistant to IFN-α

Sensitive n = 7Resistant n = 3
Control Fas Triggering Control Fas Triggering
Untreated 100  63.6 ± 5  100  97 ± 1 
IFN-α 20 U/mL  91.3 ± 4  51.7 ± 9  101 ± 6 88 ± 7  
IFN-α 100 U/mL  82.8 ± 7  48.7 ± 13 106 ± 2  88 ± 6  
IFN-α 1,000 U/mL  65.4 ± 5 25.8 ± 11  99.3 ± 6  80.3 ± 3 
Sensitive n = 7Resistant n = 3
Control Fas Triggering Control Fas Triggering
Untreated 100  63.6 ± 5  100  97 ± 1 
IFN-α 20 U/mL  91.3 ± 4  51.7 ± 9  101 ± 6 88 ± 7  
IFN-α 100 U/mL  82.8 ± 7  48.7 ± 13 106 ± 2  88 ± 6  
IFN-α 1,000 U/mL  65.4 ± 5 25.8 ± 11  99.3 ± 6  80.3 ± 3 

Values (mean ± SEM) represent colony formation as a percentage of untreated CML progenitors. For untreated cells, the mean number of CFU-C (erythroid and myeloid)/103 CD34+ plated was 105 ± 9 for responders and 112 ± 33 for nonresponders. Fas was triggered by the agonist MoAb CH11 used at the concentration of 1 μg/mL. Statistical analysis (paired t-test) showed P< .05 only in the responder group, for control versus IFN-α 100 and 1,000 U/mL; control versus Fas triggering; control + any IFN-α concentration versus control + any IFN-α concentration + Fas triggering.

Close Modal

or Create an Account

Close Modal
Close Modal